SCHEMBL7697608

SCHEMBL7697608

Brc1ccc(-c2cnc3cc4ccccc4cc3n2)cc1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
RAB9A P51151 5/20 0.56
PDGFRB P09619 1/20 0.56
KDR P35968 1/20 0.56
FLT3 P36888 1/20 0.56
MAPT P10636 4/20 0.51
ALDH1A1 P00352 2/20 0.51
GLA P06280 1/20 0.51
GAA P10253 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
TLR9 Q9NR96 1/20 0.49
BCHE P06276 1/20 0.49
KDM4E B2RXH2 2/20 0.46
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28165769 0.97 NPC1 (0.53) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL17656943 0.87 NPC1 (0.61) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL6215142 0.85 NPC1 (0.73) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL973317 0.84 NPC1 (0.68) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL30786723 0.84 NPC1 (0.68) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL28491297 0.83 SMN1; SMN2 (0.47) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL7694544 0.83 NPC1 (0.56) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL7694669 0.83 NPC1 (0.65) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL7696224 0.83 NPC1 (0.72) NPC1SMN1; SMN2RAB9APDGFRBKDR
SCHEMBL7600391 0.82 TLR9 (0.51) NPC1SMN1; SMN2RAB9APDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed